cannabis & hemp regulatory news around

Analysis

Analysis

DEA's June 29 Rescheduling Hearing: Who Just Filed to Participate and What Operators Should Watch

The broader rescheduling administrative hearing begins June 29, 2026. The slate of participants is now largely fixed after the May 28 filing deadline. The hearing record will shape what cannabis operators can expect on 280E, banking, and research access.

Analysis

TSA Medical Marijuana by State: Where Patients Actually Get Arrested at the Airport in 2026

The variable that matters in 2026 is not the TSA page. It is the airport you land at. A 28-airport breakdown of permissive, discretionary, and prohibitionist enforcement, with the source-state and destination-state details patients actually need.

Analysis

Medical vs. Recreational Cannabis After Rescheduling: The Two-Tier Federal Market

The April 2026 order created a two-tier federal cannabis market — Schedule III for medical, Schedule I for recreational. Here is what it means and what comes next.

Analysis

Trump Cannabis Rescheduling: What the April 2026 Final Order Actually Did

What the Trump administration's April 22, 2026 final order actually rescheduled, what stayed in Schedule I, and what operators and advisors should do next.

Analysis

California Vape Laws in 2026: SB 793, AB 3218 & the Unflavored Tobacco List

California bans all flavored vapes in 2026 under SB 793 + AB 3218. Only Unflavored Tobacco List (UTL) products are legal. Penalties up to $4,000 per violation.

Analysis

Is Cannabis Legal in Switzerland, Denmark & Scandinavia? 2025 European Laws

Switzerland runs a CBD-only framework with 2025 cannabis club pilots; Denmark, Sweden, and Norway laws compared for European hemp brands and travelers.

Analysis

The Hemp Regulatory Cliff: How Section 781 and the November 2026 Deadline Reshape Product Compliance

Section 781 of H.R. 5371, signed November 12, 2025, narrows the federal hemp definition and sets a compliance deadline expiring November 12, 2026.

Analysis

Federal Cannabis Rescheduling in 2026: Compliance Actions Operators Should Take Before the Rules Are Final

Executive Order 14370, signed December 18, 2025, directs the Attorney General to expedite federal cannabis rescheduling from Schedule I to Schedule III.

Analysis

Multi-State Hemp Policy Tracker Spring 2026: GA, IN, KY, MN, MO, VA, and WA Legislative Activity

Spring 2026 hemp legislation in Georgia, Indiana, Kentucky, Minnesota, Missouri, Virginia, and Washington is creating a fragmented multi-state compliance map.

Analysis

Cannabis Lab Testing Standards Tighten in 2026: Potency Audits, Lab Shopping Crackdowns, and ISO 17025

Cannabis lab testing standards in 2026 are tightening through potency audits, lab shopping crackdowns, and broader ISO 17025 accreditation expectations.

Analysis

Schedule III and Cannabis Banking: What Rescheduling Actually Changes for Payments, Lending, and Listings

Schedule III rescheduling removes Schedule I criminal risk but does not automatically unlock cannabis banking, payments, lending, or public listings in 2026.

Analysis

FDA CBD Enforcement Policy: What the White House OIRA Review Signals for Product Brands

In March 2026 the FDA sent its first CBD compliance and enforcement policy to White House OIRA review, signaling new federal expectations for hemp brands.

Analysis

2026 Extensions Act: Federal Hemp Redefinition and the 0.4mg THC Compliance Cliff

The Continuing Appropriations and Extensions Act, signed November 12, 2025, replaces the 0.3 percent THC standard with a 0.4 milligram per-container limit.

Analysis

NIST SP 800‑63‑4 Final: What 'Identity Proofing' Means for Age‑Gating Hemp‑THC and Cannabis E‑Commerce in 2026

NIST SP 800-63-4 reshapes what reasonable age-gating looks like for hemp-THC and cannabis e-commerce in 2026, even though it is not a cannabis rulebook.

Analysis

USPS Hemp CBD Shipping Policy in 2026: Pub 52 Rules, UPS Account Gating & Compliance Program

USPS still allows hemp CBD shipping in 2026 under Pub 52 § 453.37 with documentation. UPS needs a dedicated account. International mail is prohibited.

Analysis

Germany 2026 Watch: ‘Pillar 2’ Pilot Retail Projects—Compliance Building Blocks Before the First Sale

Germany's Pillar 2 pilot retail projects remain unsettled for 2026, but medical-grade compliance controls now will position operators for any approved program.

Analysis

EU 2026 CBD Reality Check: EFSA’s ~2 mg/day Safe Level and What It Means for Labels, Dossiers, and Enforcement

EFSA's provisional 2 mg per day safe intake level for CBD is reshaping EU 2026 labels, novel food dossiers, and enforcement against legacy ingestible doses.

Analysis

Hemp 'Chemical Conversion' in 2026: The Evidence Standard for Proving 'Naturally Derived' vs. 'Synthetic' Cannabinoids

Why 2026 enforcement treats many hemp products as synthetic or artificially derived, and what evidence proves cannabinoids are naturally derived from hemp.

Analysis

Medical Cannabis Telehealth in 2026: Advertising, Prescribing, and 'Online Clinic' Enforcement Trends

Medical cannabis telehealth in 2026 faces tighter remote-prescribing oversight, scrutiny of patient acquisition, and enforcement on kickback referrals.

Analysis

After Loper Bright, Round Two: The 2026 Litigation Playbook for Challenging FDA/DEA/State Hemp Rules

After Loper Bright and Corner Post, hemp operators face new 2026 litigation openings against FDA, DEA, and state rules where statutory text controls outcomes.

Analysis

Germany 2026: Ban on Telemedical Cannabis Prescriptions—Pharmacy Dispensing, Advertising, and Patient Access Changes

Germany’s medical cannabis market is facing a major compliance reset as proposed MedCanG amendments target online prescribing, telemedicine-first patient acquisition, and mail-order pharmacy dispensing. Clinics, pharmacies, importers, wholesalers, and digital platforms should begin preparing now for in-person clinical workflows, pharmacy handover requirements, and stricter HWG advertising controls.

Analysis

“Hemp Plastic” and Compostable Claims Under Fire: California SB 343, ASTM D6400, and Proof You’ll Need for 2025–2026

California is raising the bar for hemp packaging sustainability claims. As SB 343, SB 54, ASTM compostability standards, and the FTC Green Guides reshape how brands can market recyclable, compostable, biodegradable, plastic-free, and bio-based packaging, cannabis and hemp operators need audit-ready substantiation before making environmental claims.

Analysis

Canada 2025–2026: Preparing for Digital or Unified Excise Stamps—A Practical Roadmap for Cannabis Beverages

Canada signaled a shift from 13 province-specific cannabis excise stamps toward a unified national stamp, with packaging and co-pack implications for beverages.

Analysis

Federal Spotlight 2025: GAO’s Food‑Contact Substance Critique—Packaging Risk for THC/CBD Beverages

A GAO report urging FDA to strengthen its Food Contact Substances program raises packaging migration and audit risk for THC and CBD beverage brands.

Analysis

Belgium 2025: CBD at a Crossroads—FAMHP Signals Tighter Oversight While EU Novel Food Bar Remains High

Belgium FAMHP and FASFC are tightening CBD classification controls in 2025 while the EU novel food bar for ingestible cannabidiol products remains high.

Analysis

Massachusetts 2025: Social Consumption Regulations Near the Finish Line—Implications for On‑Premise THC and Hemp Drinks

Massachusetts CCC social consumption regulations took effect in early 2026, setting dual-track planning for on-premise adult-use service and hemp THC drinks.

Analysis

Canada 2025 Excise Tax Reform and Fixing Excise Stamps: What Cannabis and THC Drink Brands Should Plan For

Canada signaled 2025-2026 cannabis excise reform on the dollar-per-gram or 10 percent minimum duty and a move toward a single national excise stamp.

Analysis

UK 2025: DMCC Act Cracks Down on CBD/Hemp‑THC E‑Commerce—Subscriptions, Fake Reviews, and Drip Pricing

The UK Digital Markets, Competition and Consumers Act took effect 6 April 2025, exposing CBD e-commerce to CMA enforcement on drip pricing and reviews.

Analysis

Italy vs. Brussels: Will the EU Move Against Italy’s 2025 CBD Ban? Cross‑Border E‑Commerce Risk Map for Q4 2025

Italy Decree-Law No. 48 of 11 April 2025 sharply restricted hemp inflorescences and CBD derivatives, raising EU infringement risk for cross-border sellers.

Analysis

Ontario’s Blue Box Shake‑Up: 2025 EPR Cost Pressures and Labeling Implications for Cannabis and THC Beverages

Ontario Blue Box EPR transition under O. Reg. 391/21 is adding 2025 cost pressure and labeling scrutiny for THC and CBD beverage producers in the province.

Analysis

British Columbia’s Producer Retail Store (Farmgate) Program in 2025: What LCRB Stats Signal About Direct Sales

British Columbia LCRB weekly Producer Retail Store statistics offer a near-real-time read on 2025 farmgate pipeline activity and direct-sales sentiment.

Analysis

Massachusetts 2025 Social Consumption Draft Rules: Implications for THC Beverages and Events

Massachusetts CCC approved final social consumption rules December 11, 2025 and the Secretary promulgated them January 2, 2026, shaping THC beverage events.

Analysis

South Korea 2025: CBD Still a Narcotic—Import Bans, Branding Restrictions, and Traveler Risks

South Korea continues to treat CBD as a controlled narcotic in 2025, with the Supreme Court upholding CBD cosmetic import restrictions in a June 2025 ruling.

Analysis

Alberta 2025: Inside AGLC’s THC Potency Audit—Common Failures and How to Fix Them

Alberta AGLC 2025 secondary testing program shows potency variance and labeling issues drive most compliance breakdowns rather than contamination findings.

Analysis

Ontario 2025: OCS THC Potency Testing Pilot Results—Label Accuracy and Supplier Audits

Ontario's 2025 OCS THC potency testing pilot exposes label inflation in high-THC SKUs and reshapes supplier audits across the regulated adult-use catalog.

Analysis

Ballot‑Box Bans: Tracking 2025 City and County Votes on Intoxicating Hemp in Missouri—and How Retailers Should Pivot

Missouri cities and counties used 2025 emergency ordinances and ballot measures to restrict intoxicating hemp sales to 21-plus buyers or licensed dispensaries.

Analysis

Zero‑Tolerance Jurisdictions in 2025: UAE and Saudi Arabia Crackdowns on CBD—Travel and E‑Commerce Risk Map

The UAE under Federal Decree-Law 30 of 2021 and Saudi Arabia maintain zero-tolerance CBD enforcement in 2025, with active airport screening and mail seizures.

Analysis

No Bears, No Worms: The 2025 Multi‑State Map of “Attractive to Children” Shape Bans for Hemp and Cannabis Gummies

State attractive-to-children shape bans for hemp and cannabis gummies in 2025 are subjectively enforced, pushing brands to design for the strictest standard.

Analysis

Massachusetts’ Proposed $4.05/Gallon Hemp Beverage Tax: Price Modeling and Retail Pass‑Through Scenarios for 2026

Massachusetts is weighing a $4.05 per gallon excise on hemp beverages and CCC oversight; this models price impact and retailer pass-through scenarios.

Analysis

APAC 2025 CBD/THC Risk Map: Thailand's U‑Turn, Japan's Residue Limits, Hong Kong's Ban, and Singapore's Zero‑Tolerance

Thailand tightened, Japan moved to residue limits, Hong Kong enforces a CBD ban, and Singapore stays zero-tolerance, reshaping APAC compliance for 2025.

Analysis

AI‑Policed Ads Are Here: How Automated Scraping by FTC, FDA, and Platforms Puts Hemp/CBD Marketing at Risk in Late 2025

FTC, FDA, and platforms now use automated scraping to flag CBD and THC ad claims at scale, with faster takedowns and regulator referrals in late 2025.

Analysis

FDA’s 2025 ‘Natural Colors’ Push: Label and Claims Risks for THC & CBD Beverages

FDA's 2025 focus on naturally derived color additives raises label risk for THC and CBD beverages using spirulina, beet, or no-artificial-color claims.

Analysis

Greece 2025: Parliament Eyes Investment and Export Boost for Medical Cannabis—What GMP Exporters Must Prepare

Greece's 2025 push to expand medical cannabis exports hinges on EU-GMP readiness across GACP cultivation, EudraLex Volume 4 manufacturing, and release.

Analysis

The ABC Model Takes Over Hemp‑THC Beverages in the South: Comparing Alabama, Tennessee, and Kentucky in Late 2025

Alabama, Tennessee, and Kentucky are moving hemp-derived THC beverages to ABC three-tier distribution, age-21 gating, and alcohol-style excise in 2025.

Analysis

After the Supreme Court Opens RICO Claims for CBD Labeling: Litigation Readiness for 2025–2026

The April 2, 2025 Supreme Court ruling in Medical Marijuana, Inc. v. Horn widens civil RICO exposure for CBD label and potency claims and treble damages.

Analysis

Sober Bars and THC Mocktails in 2025: Where On‑Premise Hemp Drinks Are Actually Allowed

On-premise hemp THC drink service in 2025 splits states into allow, ban, and unclear buckets, with 21+ controls and serving caps driving license risk.

Analysis

California’s Local Patchwork on Intoxicating Hemp: County Bans, Padlocks, and Online Stings in Late 2025

California's late 2025 intoxicating hemp enforcement is a county patchwork using nuisance abatement, padlock closures, and online sting operations.

Analysis

PHMSA’s July 2025 Lithium Battery NPRMs: Vape Device Reverse Logistics, Hazmat Training, and What Changes by 2026

PHMSA's July 1, 2025 package of 17 lithium battery NPRMs reshapes vape device reverse logistics, hazmat training, and 3PL returns workflows through 2026.

Analysis

Devolution Watch: England/Wales vs. Scotland on CBD Novel Foods After the FSA’s 2025 Consultation

Great Britain's CBD novel food market faces devolution risk after the FSA's 2025 consultation, with Scotland's FSS free to diverge from England and Wales.

Analysis

Hong Kong 2025–2026: Year Two of the CBD Ban—Airport Seizures, Schedule 1 Risks, and Guidance for Travelers and Exporters

Hong Kong's CBD prohibition under Schedule 1 of the Dangerous Drugs Ordinance entered year two of zero-tolerance enforcement with continued airport seizures.

Analysis

FY2026 Ag‑FDA Appropriations Watch: A Federal Potency‑Limit Directive for Hemp? What FDA/HHS Rulemaking Could Look Like

An FY2026 Agriculture-FDA appropriations directive on intoxicating hemp could become the first durable federal framework for finished-product potency limits.

Analysis

Poland 2025 Drug Reimbursement Overhaul Meets Medical Cannabis: Pricing, Target Import, and Patient Access

Poland's 2025 Reimbursement Act reform reshapes pricing, target import, and patient access pathways for medical cannabis manufacturers and importers.

Analysis

Colombia 2025: New Foreign Trade Rules and Pharmacy Flower — An EU‑GMP Export Roadmap

Colombia's 2025 VUCE foreign trade updates and Decree 1138 of 2025 reshape medical cannabis exports and authorize pharmacy flower under EU-GMP prescription.

Analysis

Are Cannabis Terpenes the Next VOC Target? Air Permits, Odor Rules, and Ozone SIP Pressures in 2025–2026 (California)

California cannabis terpene emissions face 2025 to 2026 air-permitting scrutiny as VOCs under Clean Air Act ozone planning and SIP nonattainment pressure.

Analysis

New Jersey 2025: NJDPA Meets Cannabis E‑Commerce — 15‑Day Opt‑Out, GPC, and Youth‑Ad Targeting

New Jersey's NJDPA took effect January 15, 2025, forcing cannabis e-commerce to honor Global Privacy Control, a 15-day opt-out, and youth-ad targeting limits.

Analysis

Luxembourg’s Retail Legalization Model on the Table: Two Producers, Tight Controls—A Compliance Preview (2026 Update)

Luxembourg's concept paper outlines a tightly controlled state-run adult-use retail model with seed-to-sale tracking and an ad ban, still uncertain in 2026.

Analysis

FDA’s 2025 Food Colors Agenda Meets THC Drinks: Natural Color Additives, Labeling, and GRAS Traps

FDA's 2025 Human Foods Program signaled new natural color additive guidance, exposing THC beverages to color additive premarket review and misbranding risk.

Analysis

When Carriers Won’t Take Your Vape Returns: 2025 Universal‑Waste Policies and Reverse Logistics for Hemp Retailers

Hemp retailers in 2025 face a reverse-logistics squeeze as parcel carriers refuse universal-waste vape returns and federal lithium battery rules tighten.

Analysis

Norway 2025: Zero‑THC or Nothing—Importing CBD Without Novel Food or Trace THC

Norway's 2025 CBD import posture demands zero detectable THC, with seizures through September 2025 and Novel Food or medicines hurdles for ingestibles.

Analysis

Colombia 2025: Prescription‑Only Adult Use? Inside the Draft Decree and What It Means for Exports and Pharmacies

Colombia's July 2025 draft decree and October 2025 Decree 1138 outline a prescription-only adult-use model dispensed through pharmacies under medical-gate.

Analysis

Poland’s 2025 CBD Crosswinds: Novel Foods Enforcement and Medical Cannabis Telehealth Rollbacks

Poland in 2025 separates legal hemp from legal ingestible CBD under EU novel food rules while tightening medical cannabis telehealth prescribing.

Analysis

Florida’s Digital Bill of Rights Meets Cannabis E‑Commerce: Targeted Ads, Kids’ Data, and 2025 Enforcement Risks

Florida's Digital Bill of Rights, effective July 1, 2024, reshapes targeted ads and kids' data rules for cannabis and hemp e-commerce operators.

Analysis

‘Hemp‑Derived’ or Chemically Converted? 2025 Litigation and NAD Risks for Minor Cannabinoid Claims

Marketing minor cannabinoids as hemp-derived or naturally occurring when chemically converted is driving 2025 litigation and NAD challenges for U.S. brands.

Analysis

Caffeine + THC Energy Seltzers Under the Microscope in 2025: Ingredient Bans, Warnings, and Youth-Appeal Risk

Regulators treat caffeine plus intoxicating cannabinoid drinks as a higher-risk category in 2025, raising ingredient ban, warning, and youth-appeal exposure.

Analysis

High on Hemp in Illinois: Chicago’s 260+ Retailers, Local Ordinances, and a 2025–2026 Compliance Forecast

Chicago's 260-plus hemp cannabinoid retailers are driving 2025-2026 local ordinance activity that will reshape Illinois compliance for operators and brands.

Analysis

Poland 2025: CBD at Risk and Medical Cannabis Tightens—Retail and Cross‑Border Compliance Map

Poland's 2025 enforcement shift tightens medical cannabis remote prescribing and pressures CBD retail, reshaping cross-border supply for importers and brands.

Analysis

Greece 2025: New Pharmaceutical Safety-Feature Rules—Serialization and Repackaging Controls for Cannabis-Derived Medicines

Greece's 2025 Falsified Medicines Directive update adds new serialization and repackaging controls for cannabis-derived prescription medicines.

Analysis

Poland’s 2025 Reset: Telemedicine Crackdown, CBD Novel Food Enforcement, and What Importers Must Change

Poland's 2025 reset targets receptomaty telemedicine and enforces CBD novel food rules, forcing importers to overhaul sourcing and clinical channels.

Analysis

Costa Rica's Hemp Buildout in 2025: 57 Licenses Issued—Novel Food Compliance, Claims, and Export Readiness

Costa Rica's Law 10113 framework reached 57 hemp authorizations in 2025, splitting compliance between MAG activity licenses and Ministry of Health rules.

Analysis

Panama's Seven Licensees: GMP, Labeling, and Import/Export Rules Before First Medical Cannabis Sales

Panama's MINSA confirmed seven Ley 242 medical cannabis licenses, shifting compliance focus to GMP readiness, product authorization, and import-export work.

Analysis

Ghana 2025: 0.3% THC Guidelines Headed to Parliament—Licensing, Testing, and Labeling Under the New Regime

Ghana's government will lay 0.3% THC cultivation guidelines before Parliament in late 2025, anchored to the Narcotics Control Commission Act framework.

Analysis

India 2025: FSSAI’s License Renewal Overhaul Meets CBD—Food vs. AYUSH, Imports, and E‑Commerce

India's 2025 FSSAI license renewal overhaul reshapes CBD compliance for food and AYUSH pathways, with new implications for imports and e-commerce listings.

Analysis

Pennsylvania's Emerging Path for Hemp‑THC Drinks: LCB Oversight, 21+ Zones, or Dispensary‑Only?

Pennsylvania faces three competing models for hemp-THC beverages: PLCB alcohol oversight, Department of Agriculture food rules, or dispensary-only channels.

Analysis

Missouri 2026: The Alcohol‑Model Ballot Initiative for Cannabis and Hemp—What It Would Mean for THC Drinks

A September 2025 Missouri initiative would replace the constitutional cannabis program with an alcohol-model framework covering THC and hemp beverages.

Analysis

After the D.C. Circuit Pauses Parts of EPA’s PFAS Rule: What THC and CBD Beverage Plants Must Change Now

EPA's September 2025 request to the D.C. Circuit to vacate parts of its PFAS drinking water rule reshapes water testing duties for THC and CBD beverage plants.

Analysis

Could USPS Ship Cannabis? Inside the 2025 Bill and a Compliance Map if It Passes

A 2025 congressional bill would authorize USPS to carry state-legal cannabis, creating a federal last-mile compliance map operators should pressure-test now.

Analysis

Can States Block Common Carriers From Delivering Hemp‑THC? FAAAA Preemption Meets the Farm Bill in 2025

FAAAA preemption may limit how states block common carriers from delivering federally lawful hemp-THC products under the 2018 Farm Bill in 2025 litigation.

Analysis

The 2025 Wave of Influencer Class Actions: How Hemp and CBD Brands Should Rewrite Disclosures and Contracts

A 2025 wave of influencer class actions alleges hemp and CBD brands ran sponsored posts without FTC-compliant disclosures, raising contract review risk.

Analysis

Poland 2025: Telemedicine Crackdown and a Possible CBD Ban—Legal Outlook for Retailers and Importers

Poland's 2025 telemedicine clampdown and a possible CBD ban reshape the legal outlook for hemp wellness retailers and medical-patient supply importers.

Analysis

State AGs Escalate Against Synthetic Hemp: Inside SABER’s 2025 Playbook and Retailer Defense Tactics

The SABER state attorneys general consortium escalated 2025 enforcement against synthetic hemp cannabinoids, driving new retailer defense tactics nationwide.

Analysis

Morocco 2025: First Legal Cannabis Exports and 67 Approved Products—EU‑GMP and Export Docs Explained

Morocco shipped its first legal medical cannabis export in 2025 and approved 67 products, raising the bar on EU-GMP standards and export documentation.

Analysis

EU 2025: EFSA's 2 mg/day CBD Limit—Labels, Dossiers, and Member-State Enforcement

EFSA's September 2025 opinion proposes a 2 mg per day CBD acceptable daily intake, reshaping EU Novel Food dossiers, labels, and member-state enforcement.

Analysis

DOT Hair Testing Is Back on the Table: What Cannabis Employers Should Prep for in Late 2025

HHS is advancing hair testing for DOT safety-sensitive roles, signaling a longer cannabis detection window that employers must prep for in late 2025.

Analysis

EU Marketplaces Are Cleaning House: DSA Enforcement Risks for CBD and ‘Neo‑Cannabinoid’ Listings in 2025

The EU Digital Services Act drove 2025 marketplace enforcement against CBD and neo-cannabinoid listings, redefining seller liability and platform duties.

Analysis

ACH Under the Microscope: Nacha’s 2025–2026 Fraud Rules for Hemp/THC E‑Commerce

Nacha's 2025-2026 fraud rules add ACH risk-monitoring duties for hemp and THC e-commerce merchants leaning on account-to-account payments as cards tighten.

Analysis

“Made in USA” Claims for Hemp and CBD Under Fire: 2025 FTC Enforcement Lessons for Labels and Marketplaces

FTC 2025 Made in USA enforcement against hemp and CBD brands extends to Amazon and Walmart marketplaces, raising the evidentiary bar for origin label claims.

Analysis

Post‑Chevron Compliance: How Loper Bright Is Changing FDA/FTC/DEA Playbooks for Cannabis in 2025–2026

After Loper Bright ended Chevron deference, FDA, FTC, and DEA cannabinoid rules face independent judicial review, reshaping 2025-2026 compliance playbooks.

Analysis

EFSA's September 2025 CBD Safety Update: What It Signals for EU Novel Food Authorizations in 2026

EFSA's September 8, 2025 CBD safety update raises the dose-response and impurity bar for EU Novel Food applications heading into 2026 authorizations.

Analysis

Post‑Chevron Reality for Cannabis and Hemp: How Loper Bright and Corner Post Reshape FDA and DEA Rule Challenges in 2025–2026

Loper Bright and Corner Post expand cannabis and hemp APA challenges to FDA and DEA rules, raising 2025-2026 stakes for ambiguous statutes and rescheduling.

Analysis

Antitrust and the Three‑Tier Edge: When Beer Distributors Carry THC Seltzers in 2025

Beer distributors carrying hemp THC seltzers in late 2025 face antitrust and three-tier exposure as TTB, state ABCs, and DOJ test alcohol-style structures.

Analysis

Climate Disclosure Comes for THC Drinks: California SB 253/261 and Scope 3 Packaging Emissions Planning

California SB 253 and SB 261 climate disclosure laws are pushing 2025 Scope 3 packaging data requests down to THC beverage co-packers and aluminum suppliers.

Analysis

NAD 2025 vs. CBD/THC Ads: Fast‑Acting Claims, Microdosing, and Kids’ Appeal Under the Microscope

NAD, CARU, and FTC stepped up 2025 review of hemp CBD and THC ads, targeting fast-acting nano claims, microdosing language, and youth-appeal creative.

Analysis

CANNRA’s 2025 Model Policy for Intoxicating Hemp: Which States Will Adopt It and When

The Cannabis Regulators Association 2025 Model Policy for intoxicating hemp is shaping more than 80 state bills across 27 jurisdictions on THC drinks.

Analysis

NAD in 2025: Claim Substantiation Lessons for CBD and Cannabinoid Beverages

NAD's 2025 enforcement against unsubstantiated health claims sets a tighter substantiation bar for CBD, CBG, and cannabinoid beverage advertising.

Analysis

Marketplace Facilitator Taxes Meet Hemp‑THC: Who Collects on TikTok Shop, Amazon, and Beyond?

Hemp-THC sellers face a state-by-state tax patchwork in 2026 — marketplace facilitator rules rarely apply when Amazon and TikTok Shop ban the listings.

Analysis

After Loper Bright: How Ending Chevron Deference Rewrites Cannabis and Hemp Rulemaking

Loper Bright ended Chevron deference in June 2024, exposing FDA, USDA, DEA, DOT, and CPSC cannabis and hemp rules to direct statutory challenges in 2025.

Analysis

Do THC Beverages Need Child‑Resistant Packaging? The 2025 Patchwork Across States and What CPSC Actually Covers

CPSC and the PPPA do not require child-resistant closures on THC beverages, leaving 2025 brands to navigate a state-by-state patchwork of CR and warning rules.

Analysis

The 2025 Analog Ban Wave: How States Are Targeting HHC, THCP, THC‑O and "Synthetics"—A Practical Map for Formulators

A 2025 wave of state laws bans HHC, THCP, THC-O and other hemp analogs, using broad isomer and synthetic language that reshapes formulator R&D playbooks.

Analysis

Hemp THC Vending Machines: Biometric Age Checks, ADA/BIPA Exposure, and Where They're Legal in 2025

Hemp THC vending machines in 2025 face a patchwork of state legality, biometric age-verification rules, ADA accessibility duties, and BIPA litigation exposure.

Analysis

California's Delete Act Collides with Cannabis Loyalty: Data Broker, DROP, and Vendor Risk in 2025–2026

California's Delete Act (SB 362) forces cannabis loyalty programs and adtech vendors to register as brokers and honor DROP deletion requests by August 2026.

Latest Articles

Log In

Cannabisregulations.ai individual state-trained AI cannabis and hemp compliance chatbot agents assist you in understanding regulations faster and better, making compliance easier and more affordable.

info@cannabisregulations.ai
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
hemp & cannabis ai Solutions
State Hemp Law MapFor Hemp THC BeveragesFor Hemp & Cannabis BrandsFor MarketersFor OperatorsFor LawyersFor DispensariesFor Tech ProvidersFor Social EquityFor RegulatorsFor Alcohol / Beverage
Featured reading
Optimize with AINY Market GuideDelaware ComplianceWhy Our AI WinsOhio Regulation AI
Quick Links
Try Free, NOW!Feedback FormFeaturesContactCannabis Lawyer DirectoryBlog
THC/ CBD news by country
US Hemp Law By State MapIs CBD Legal In Italy?Is CBD Legal In Saudi Arabia?Is CBD Legal In Japan?Is Cannabis Legal In Puerto Rico?China RegulationsBrazil RegulationsMexico RegulationsPuerto Rico RegulationsSpain RegulationsIsrael RegulationsCanada Regulations
Cannabis & Hemp ai guides
Hemp Manufacturer PromptsHemp & Cannabis Brand PromptsHemp Beverage PromptsContent Creation PromptsCultivation SOP PromptsDispensary SOP PromptsSales Teams AI Prompts
is hemp derived delta 9 thc legal?
State Delta 9 THC MapTexasFloridaCaliforniaGeorgiaNew YorkIllinois
regultory content types
Court Filing RecapsFAQAnalysisGuideNews
most popular posts
2026 California Vape LawsNJ Hemp & THCa Ban 2026Cannabis & Hemp Laws By State 2026Google, Meta, & TikTok Ads For Cannabis 2026Is HHC Legal in UK & EU? 2026Cannabinoid Barcodes 2026 Changes
Popular regulatory topics
Marketing RegulatoryTravel Regulatory Banking & PaymentsRetail CompliancePackaging & LabelingLicensing & PermitsCannabis & Hemp TaxSOP's
travel & Transportation regulations
TSA Update: Flying With HempCan You Fly With THC Drinks?USPS/ Fedex Hemp ShippingUSPS Pub 52 Hemp Shipping
Policies
Terms of ServiceDisclaimerPrivacy PolicyEnd User License Agreement (EULA)Refund/ Cancellation PolicyAffiliate AgreementShipping Policy
All rights reserved. ComplyAssistAI LLC, 2810 N Church St, Unit 671821, Wilmington, DE 19802